Williams Jones Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
WA
AFG
GIC
IHL
EAM
Williams Jones Wealth Management's IBB Position: Q2 2026 in Review
Williams Jones Wealth Management reduced its iShares Biotechnology ETF (IBB) stake by 3.7% in Q2 2026, selling an estimated $223K and leaving 33,917 shares worth $6.45M. The position accounts for 0.07% of the portfolio, ranked #128.
Williams Jones Wealth Management first reported a position in IBB in Q3 2019 and has held it in 28 quarters since. The position peaked at $17.5M in Q2 2021. 523 funds tracked by Wall St. Rank hold IBB as of Q2 2026.
- Williams Jones Wealth Management held 33,917 shares of iShares Biotechnology ETF worth $6.45M as of Q2 2026.
- Williams Jones Wealth Management sold 1,300 iShares Biotechnology ETF shares in Q2 2026, an estimated $223K.
- iShares Biotechnology ETF made up 0.07% of Williams Jones Wealth Management's portfolio in Q2 2026, its #128 holding.
- Williams Jones Wealth Management first reported a position in iShares Biotechnology ETF in Q3 2019 and has held it in 28 quarters since.
- Williams Jones Wealth Management's iShares Biotechnology ETF position peaked at $17.5M in Q2 2021.
- 523 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.
Based on Williams Jones Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.